alkenes has been researched along with Amyloid Angiopathy, Cerebral in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgess, A; Hynynen, K; Klibanov, AL; Moffatt, C; Nhan, T | 1 |
| Bacskai, BJ; Finn, MB; Garcia-Alloza, M; Holtzman, DM; Hyman, BT; Koenigsknecht-Talboo, J; Meyer-Luehmann, M; Parsadanian, M | 1 |
| Bacskai, BJ; Betensky, R; Borrelli, LA; Fine, S; Frosch, MP; Garcia-Alloza, M; Greenberg, SM; Lattarulo, C; Prada, C | 1 |
| Bales, KR; Fryer, JD; Holtzman, DM; Parsadanian, M; Paul, SM; Simmons, K; Sullivan, PM | 1 |
| Bacskai, BJ; Betensky, RA; Domnitz, SB; Frosch, MP; Garcia-Alloza, M; Greenberg, C; Greenberg, SM; Hyman, BT; Purcell, SM; Rebeck, GW; Robbins, EM | 1 |
5 other study(ies) available for alkenes and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Blood-Brain Barrier; Brain; Cerebral Amyloid Angiopathy; Drug Delivery Systems; Female; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence, Multiphoton; Permeability; Plaque, Amyloid; Stilbenes; Ultrasonics | 2014 |
Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice.
Topics: Age Factors; Alkenes; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Antibodies; Benzene Derivatives; Calcium-Binding Proteins; Cell Count; Cell Movement; Cerebral Amyloid Angiopathy; CX3C Chemokine Receptor 1; Disease Models, Animal; Green Fluorescent Proteins; Leukocyte Common Antigens; Mice; Mice, Transgenic; Microfilament Proteins; Microglia; Plaque, Amyloid; Receptors, Chemokine; Stilbenes | 2008 |
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.
Topics: Alkenes; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzene Derivatives; Cerebral Amyloid Angiopathy; Cyclic N-Oxides; Dipeptides; Fluorescent Dyes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Transgenic; Minocycline; Oxidative Stress; Presenilin-1; Protease Inhibitors; Reactive Oxygen Species; Simvastatin; Statistics as Topic; Stilbenes; Time Factors | 2009 |
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Benzoates; Blood Vessels; Cerebral Amyloid Angiopathy; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid | 2005 |
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene Derivatives; Cerebral Amyloid Angiopathy; Craniotomy; Disease Models, Animal; Disease Progression; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Kinetics; Meninges; Mice; Mice, Transgenic; Plaque, Amyloid; Skin Window Technique; Stilbenes | 2006 |